Scotland’s cost regulator rejects Vertex cystic fibrosis drugsScotland’s cost-effectiveness body has rejected regular NHS funding for Vertex’s cystic fibrosis drugs Orkambi and Symkevi because of Share XScotland’s cost regulator rejects Vertex cystic fibrosis drugshttps://pharmaphorum.com/news/scotlands-cost-regulator-rejects-vertex-cystic-fibrosis-drugs/
Minister says using generic CF drug is an option in Orkambi rowVertex is coming under increased pressure to sign a deal with the NHS covering its Orkambi cystic fibrosis Share XMinister says using generic CF drug is an option in Orkambi rowhttps://pharmaphorum.com/news/minister-says-using-generic-cf-drug-is-an-option-in-orkambi-row/
Orkambi parents start ‘buyers club’ to import generic version of CF drugA group of parents in the UK have taken matters into their own hands in an effort to Share XOrkambi parents start ‘buyers club’ to import generic version of CF drughttps://pharmaphorum.com/news/orkambi-parents-start-buyers-club-to-import-generic-version-of-cf-drug/
Vertex selects its triple for cystic fibrosisVertex Pharma has chosen the three-drug combination it intends to submit for approval later this year for cystic Share XVertex selects its triple for cystic fibrosishttps://pharmaphorum.com/news/vertex-selects-triple-cystic-fibrosis/
NHS England improves offer to Vertex over CF drugsNHS officials in England have made an improved two-year pricing deal to Vertex Pharmaceuticals in a bid to Share XNHS England improves offer to Vertex over CF drugshttps://pharmaphorum.com/news/nhs-england-improves-offer-to-vertex-over-cf-drugs/
Health secretary hints at ‘constructive’ talks over CF drugsHealth secretary Matt Hancock has offered hope to thousands of people in the UK who have been denied Share XHealth secretary hints at ‘constructive’ talks over CF drugshttps://pharmaphorum.com/news/health-secretary-hancock-hints-at-constructive-talks-vertex/
Market access roundup: Government grillings for Vertex and US pharmaIt was a month characterised by governments butting heads with pharma over pricing both in the UK and Share XMarket access roundup: Government grillings for Vertex and US pharmahttps://pharmaphorum.com/views-analysis-market-access/market-access-roundup-government-grillings-vertex-us-pharma-pricing/
Vertex CEO hints at ‘new ideas’ to bring Orkambi to UK patientsVertex CEO Jeffrey Leiden has offered an olive branch to negotiators in the UK that could see the Share XVertex CEO hints at ‘new ideas’ to bring Orkambi to UK patientshttps://pharmaphorum.com/news/vertex-ceo-hints-at-new-ideas-to-bring-orkambi-to-uk-patients/
UK politicians to grill Vertex CEO over CF price drug rowThe CEO of Vertex Pharmaceuticals is to give evidence before influential UK politicians on Thursday, who are investigating Share XUK politicians to grill Vertex CEO over CF price drug rowhttps://pharmaphorum.com/news/uk-politicians-to-grill-vertex-ceo-over-cf-price-drug-row/
